Versigent (NYSE:VGNT) Director Kevin Clark Sells 47,761 Shares of Company Stock

Versigent (NYSE:VGNT) Director Kevin Clark sold 47,761 shares of the business’s stock in a transaction on Thursday, October 8th. The shares were sold at an average price of $44.36, for a total transaction of $2,118,677.96. Following the sale, the director directly owned 27,571 shares of the company’s stock, valued at $1,223,049.56. This represents a 63.40% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Versigent Price Performance

VGNT stock opened at $44.31 on Friday. The stock has a market cap of $3.14 billion and a P/E ratio of 23.08. Versigent has a 12 month low of $26.34 and a 12 month high of $50.88. The business has a 50-day moving average of $46.37. The company has a quick ratio of 1.09, a current ratio of 1.40 and a debt-to-equity ratio of 7.29.

Versigent (NYSE:VGNT) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $1.92 earnings per share for the quarter, beating analysts’ consensus estimates of $1.58 by $0.34. The company had revenue of $2.44 billion for the quarter, compared to the consensus estimate of $2.29 billion. Sell-side analysts forecast that Versigent will post 7.23 EPS for the current fiscal year.

Versigent Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, September 18th. Stockholders of record on Friday, September 4th were given a dividend of $0.13 per share. The ex-dividend date of this dividend was Friday, September 4th. This represents a $0.52 dividend on an annualized basis and a dividend yield of 1.2%.

Institutional Trading of Versigent

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Allianz Asset Management GmbH purchased a new position in shares of Versigent in the 2nd quarter valued at $20,602,000. HBK Investments L P purchased a new stake in shares of Versigent during the 2nd quarter worth $14,439,000. Steamboat Capital Partners LLC purchased a new stake in shares of Versigent during the 2nd quarter worth $10,385,000. WINTON GROUP Ltd purchased a new stake in shares of Versigent during the 2nd quarter worth $8,397,000. Finally, Nan Shan Life Insurance Co. Ltd. bought a new stake in Versigent during the second quarter valued at about $5,400,000.

Analyst Ratings Changes

VGNT has been the subject of a number of research reports. TD Cowen boosted their price target on Versigent from $49.00 to $58.00 and gave the company a “buy” rating in a report on Wednesday, August 5th. The Goldman Sachs Group reduced their price objective on Versigent from $59.00 to $58.00 and set a “buy” rating on the stock in a report on Tuesday. Argus lifted their target price on Versigent from $50.00 to $54.00 and gave the company a “buy” rating in a research report on Thursday, August 13th. Evercore reiterated an “outperform” rating and issued a $65.00 target price on shares of Versigent in a report on Monday, August 10th. Finally, Oppenheimer set a $50.00 price target on Versigent in a research report on Tuesday, July 21st. Eleven equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat, Versigent has a consensus rating of “Moderate Buy” and an average target price of $53.92.

Versigent Company Profile

Versigent PLC is involved in the design, manufacturing and delivery of low and high voltage power electrical architectures. Versigent PLC is based in SCHAFFHAUSEN, Switzerland.